Identification of a novel cerebral malaria susceptibility locus (Berr5) on mouse chromosome 19

Genes and Immunity

Volumn 11, Issue 4, 2010, Pages 310-318

  Berghout, J ^a   Min Oo, G ^a   Tam, M ^b   Gauthier, S ^a   Stevenson, M ^b   Gros, P ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Genetics; Ifit; Inflammation; Malaria; Plasmodium berghei; QTL

Indexed keywords

CHROMOSOME PROTEIN; INTERLEUKIN 4; PROTEIN EAE19; PROTEIN TRL 4; PROTEIN TSIQ2; UNCLASSIFIED DRUG;

ALLELE; ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; BRAIN MALARIA; C57BL 6 MOUSE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 19; CHROMOSOME IDENTIFICATION; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC CROSS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; MALE; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; SURVIVAL TIME;

ALLELES; ANIMALS; CHROMOSOME MAPPING; GENETIC PREDISPOSITION TO DISEASE; LOD SCORE; MALARIA, CEREBRAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PLASMODIUM BERGHEI; QUANTITATIVE TRAIT LOCI;

PLASMODIUM BERGHEI;

EID: 77953121361     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2009.79     Document Type: Article

References (41)

1. WHO. Malaria. In: World Health Organization 2007.
2. Lamb TJ, Brown DE, Potocnik AJ, Langhorne J. Insights into the immunopathogenesis of malaria using mouse models. Expert Rev Mol Med 2006; 8: 1-22.
3. Coltel N, Combes V, Hunt NH, Grau GE. Cerebral malaria\a neurovascular pathology with many riddles still to be solved. Curr Neurovasc Res 2004; 1: 91-110.
4. Nyangoto EO. Cell-mediated effector molecules and complicated malaria. Int Arch Allergy Immunol 2005; 137: 326-342.
5. Kwiatkowski DP. How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet 2005; 77: 171-192.
6. Mazier D, Nitcheu J, Idrissa-Boubou M. Cerebral malaria and immunogenetics. Parasite Immunol 2000; 22: 613-623.
7. Sexton AC, Good RT, Hansen DS, D'Ombrain MC, Buckingham L, Simpson K et al. Transcriptional profiling reveals suppressed erythropoiesis, up-regulated glycolysis, and inter-feron-associated responses in murine malaria. J Infect Dis 2004; 189: 1245-1256.
8. Delahaye NF, Coltel N, Puthier D, Flori L, Houlgatte R, Iraqi FA et al. Gene-expression profiling discriminates between cerebral malaria (CM)-susceptible mice and CM-resistant mice. J Infect Dis 2006; 193: 312-321.
9. Lovegrove FE, Gharib SA, Patel SN, Hawkes CA, Kain KC, Liles WC. Expression microarray analysis implicates apopto-sis and interferon-responsive mechanisms in susceptibility to experimental cerebral malaria. Am J Pathol 2007; 171: 1894-1903.
10. Hansen AM, Ball HJ, Mitchell AJ, Miu J, Takikawa O, Hunt NH. Increased expression of indoleamine 2,3-dioxygenase in murine malaria infection is predominantly localised to the vascular endothelium. Int J Parasitol 2004; 34: 1309-1319.
11. Senaldi G, Shaklee CL, Guo J, Martin L, Boone T, Mak TW et al. Protection against the mortality associated with disease models mediated by TNF and IFN-gamma in mice lacking IFN regulatory factor-1. J Immunol 1999; 163: 6820-6826.
12. Engwerda CR, Mynott TL, Sawhney S, De Souza JB, Bickle QD, Kaye PM. Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J Exp Med 2002; 195: 1371-1377.
13. Patel SN, Berghout J, Lovegrove FE, Ayi K, Conroy A, Serghides L et al. C5 deficiency and C5a or C5aR blockade protects against cerebral malaria. J Exp Med 2008; 205: 1133-1143.
14. Rogerson SJ, Grau GE, Hunt NH. The microcirculation in severe malaria. Microcirculation 2004; 11: 559-576.
15. Pais TF, Chatterjee S. Brain macrophage activation in murine cerebral malaria precedes accumulation of leukocytes and CD8+ T cell proliferation. J Neuroimmunol 2005; 163: 73-83.
16. Renia L, Potter SM, Mauduit M, Rosa DS, Kayibanda M, Deschemin JC et al. Pathogenic T cells in cerebral malaria. Int J Parasitol 2006; 36: 547-554.
17. Nagayasu E, Nagakura K, Akaki M, Tamiya G, Makino S, Nakano Y et al. Association of a determinant on mouse chromosome 18 with experimental severe Plasmodium berghei malaria. Infect Immun 2002; 70: 512-516.
18. Bagot S, Campino S, Penha-Goncalves C, Pied S, Cazenave PA, Holmberg D. Identification of two cerebral malaria resistance loci using an inbred wild-derived mouse strain. Proc Natl Acad Sci USA 2002; 99: 9919-9923.
19. Campino S, Bagot S, Bergman ML, Almeida P, Sepulveda N, Pied S et al. Genetic control of parasite clearance leads to resistance to Plasmodium berghei ANKA infection and confers immunity. Genes Immun 2005; 6: 416-421.
20. Ohno T, Nishimura M. Detection of a new cerebral malaria susceptibility locus, using CBA mice. Immunogenetics 2004; 56: 675-678.
21. Penet MF, Viola A, Confort-Gouny S, Le Fur Y, Duhamel G, Kober F et al. Imaging experimental cerebral malaria in vivo: significant role of ischemic brain edema. J Neurosci 2005; 25: 7352-7358.
22. Boyartchuk VL, Broman KW, Mosher RE, D'Orazio SE, Starnbach MN, Dietrich WF. Multigenic control of Listeria monocytogenes susceptibility in mice. Nat Genet 2001; 27: 259-260.
23. Haldar K, Murphy SC, Milner DA, Taylor TE. Malaria: mechanisms of erythrocytic infection and pathological correlates of severe disease. Annu Rev Pathol 2007; 2: 217-249.
24. Hunt NH, Grau GE. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol 2003; 24: 491-499.
25. Clark TG, Diakite M, Auburn S, Campino S, Fry AE, Green A et al. Tumor necrosis factor and lymphotoxin-alpha polymorphisms and severe malaria in African populations. J Infect Dis 2009; 199: 569-575.
26. Campanella GS, Tager AM, El Khoury JK, Thomas SY, Abrazinski TA, Manice LA et al. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc Natl Acad Sci USA 2008; 105: 4814-4819.
27. Bluyssen HA, Vlietstra RJ, Faber PW, Smit EM, Hagemeijer A, Trapman J. Structure, chromosome localization, and regulation of expression of the interferon-regulated mouse Ifi54/Ifi56 gene family. Genomics 1994; 24: 137-148.
28. Guo J, Peters KL, Sen GC. Induction of the human protein P56 by interferon, double-stranded RNA, or virus infection. Virology 2000; 267: 209-219.
29. Fensterl V, White CL, Yamashita M, Sen GC. Novel characteristics of the function and induction of murine p56 family proteins. J Virol 2008; 82: 11045-11053.
30. Berchtold S, Manncke B, Klenk J, Geisel J, Autenrieth IB, Bohn E. Forced IFIT-2 expression represses LPS induced TNF-alpha expression at posttranscriptional levels. BMC Immunol 2008; 9: 75.
31. Strasser A, Jost PJ, Nagata S. The many roles of FAS receptor signaling in the immune system. Immunity 2009; 30: 180-192.
32. Ohno T, Kobayashi F, Nishimura M. Fas has a role in cerebral malaria, but not in proliferation or exclusion of the murine parasite in mice. Immunogenetics 2005; 57: 293-296.
33. Villa-Morales M, Santos J, Fernandez-Piqueras J. Functional Fas (Cd95/Apo-1) promoter polymorphisms in inbred mouse strains exhibiting different susceptibility to gamma-radiation-induced thymic lymphoma. Oncogene 2006; 25: 2022-2029.
34. Mitsos LM, Cardon LR, Ryan L, LaCourse R, North RJ, Gros P. Susceptibility to tuberculosis: a locus on mouse chromosome 19 (Trl-4) regulates Mycobacterium tuberculosis replication in the lungs. Proc Natl Acad Sci USA 2003; 100: 6610-6615.
35. Choi P, Xanthaki D, Rose SJ, Haywood M, Reiser H, Morley BJ. Linkage analysis of the genetic determinants of T-cell IL-4 secretion, and identification of Flj20274 as a putative candidate gene. Genes Immun 2005; 6: 290-297.
36. Yanez DM, Manning DD, Cooley AJ, Weidanz WP, van der Heyde HC. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J Immunol 1996; 157: 1620-1624.
37. Yoshimoto T, Takahama Y, Wang CR, Yoneto T, Waki S, Nariuchi H. A pathogenic role of IL-12 in blood-stage murine malaria lethal strain Plasmodium berghei NK65 infection. J Immunol 1998; 160: 5500-5505.
38. Butterfield RJ, Blankenhorn EP, Roper RJ, Zachary JF, Doerge RW, Teuscher C. Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis. Am J Pathol 2000; 157: 637-645.
39. Fortin A, Diez E, Rochefort D, Laroche L, Malo D, Rouleau GA et al. Recombinant congenic strains derived from A/J and C57BL/6J: a tool for genetic dissection of complex traits. Genomics 2001; 74: 21-35.
40. Broman KW. Mapping quantitative trait loci in the case of a spike in the phenotype distribution. Genetics 2003; 163: 1169-1175.
41. Marquis JF, Nantel A, LaCourse R, Ryan L, North RJ, Gros P. Fibrotic response as a distinguishing feature of resistance and susceptibility to pulmonary infection with Mycobacterium tuberculosis in mice. Infect Immun 2008; 76: 78-88.